A recent case report published in Health Sciences and Diseases presents a rare instance of multifocal tuberculosis affecting the meninges and lymph nodes in a 24-month-old infant from the Congo. This form of tuberculosis, characterized by the simultaneous involvement of at least two non-contiguous sites, indicates the haematogenous spread of Mycobacterium tuberculosis and represents a severe, often misdiagnosed form of the disease. The infant's condition underscores the complexities of diagnosing tuberculosis in children, especially in resource-limited settings where delayed diagnosis is common due to the insidious and non-specific clinical presentation.
Tuberculous meningitis, one of the most serious extrapulmonary manifestations of tuberculosis, carries a high mortality rate of 20–30 per cent and results in neurological sequelae in more than half of survivors. The presence of cervical lymphadenopathy associated with deteriorating neurological status, fever, and convulsions should raise suspicion of tuberculous dissemination to the meninges. This case highlights the importance of early diagnosis and the clinical diversity of paediatric multifocal tuberculosis. The use of the GeneXpert MTB/RIF test on cerebrospinal fluid proves crucial in settings with limited diagnostic facilities, enabling rapid confirmation and the immediate initiation of treatment.
According to the World Health Organization's Global Tuberculosis Report 2023, tuberculosis remains a significant public health challenge worldwide. The report emphasizes the need for improved diagnosis and treatment of tuberculosis, particularly in low- and middle-income countries. In children, tuberculous meningitis is a severe form of the disease that requires prompt diagnosis and treatment to prevent long-term neurological damage and death.
The case report emphasizes that multifocal tuberculosis in children remains a diagnostic challenge, particularly in resource-limited settings. The clinical presentation of the disease can be non-specific, making it difficult to diagnose without advanced laboratory facilities. The use of GeneXpert MTB/RIF test on cerebrospinal fluid has been shown to be effective in rapid diagnosis of tuberculous meningitis, enabling healthcare providers to initiate treatment promptly.
Honoré Ntangi Buta Batala, Calvin Kiala Luyeye, Piejetty Tembele Nkosi, Pantaleon Lewo Di Mputu, and Aimée Luyindula are the authors of the case report, which was published in Health Sciences and Diseases. The report highlights the need for increased awareness of multifocal tuberculosis in children and the importance of early diagnosis and treatment. The authors emphasize that a high index of suspicion is necessary for the diagnosis of tuberculous meningitis, particularly in resource-limited settings.
The World Health Organization has emphasized the importance of using GeneXpert MTB/RIF test for the diagnosis of tuberculosis, particularly in low- and middle-income countries. The test has been shown to be effective in rapid diagnosis of tuberculosis, enabling healthcare providers to initiate treatment promptly. In addition, the WHO has emphasized the need for improved diagnosis and treatment of tuberculosis, particularly in children.
The case report concludes that early diagnosis and treatment of multifocal tuberculosis in children are critical to prevent long-term neurological damage and death. The use of GeneXpert MTB/RIF test on cerebrospinal fluid is a valuable tool in the diagnosis of tuberculous meningitis, particularly in resource-limited settings. Further research is needed to improve the diagnosis and treatment of multifocal tuberculosis in children.
Key points
- * A 24-month-old Congolese infant was diagnosed with multifocal tuberculosis affecting the meninges and lymph nodes. * Tuberculous meningitis carries a high mortality rate of 20–30 per cent and results in neurological sequelae in more than half of survivors. * The use of GeneXpert MTB/RIF test on cerebrospinal fluid is crucial in settings with limited diagnostic facilities, enabling rapid confirmation and the immediate initiation of treatment.
